Lupin Share Price

ABOUT Lupin

• Industry Biotechnology & Drugs
• ISIN INE326A01037
• BSE Code 500257
• NSE Code LUPIN

Lupin Limited is a global pharmaceutical company, with products distributed in over 100 markets. The Company specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients (API). It operates predominantly in India and the United States across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. The Company has a presence in the cardiovascular, diabetology, asthama, pediatrics, central nervous system, gastro-intestinal, anti-infectives and nonsteroidal anti-inflammatory drug therapy segments and also operates in the anti-TB and cephalosporins segments. Its generic formulations include Filgrastim, Pegfilgrastim, Etanercept and Albuterol, among others. Its diabetes brands include ONDERO and ONDERO MET. Its other brands include AntaGolin, RyChol, and NeuroVance, among others.

MANAGEMENT

• Vinita Gupta Chief Executive Officer, Executive Director
• Ramesh Swaminathan Executive Director, Global Chief Financial Officer, Chief Risk Officer and Head of API Plus SBU
• Rajendra Chunodkar President - Manufacturing Operations
• Fabrice Egros President - Corporate Development and Growth Markets
• Spiro Gavaris President - U.S. Generics
• Naresh Gupta President - API Plus and Global TB
• Rajender Kamboj President - Novel Drug Discovery and Development
• Cyrus Karkaria President - Biotechnology
• Sunil Makharia President - Finance
• Sofia Mumtaz President - Legal, Canada and APAC